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Deletion of a trypanosome telomere leads to loss
of silencing and progressive loss of terminal DNA
in the absence of cell cycle arrest
Lucy Glover, Sam Alsford, Caroline Beattie and David Horn*
London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK
Eukaryotic chromosomes are capped with telo-
meres which allow complete chromosome replica-
tion and prevent the ends from being recognized
by the repair machinery. The African trypanosome,
Trypanosoma brucei, is a protozoan parasite where
antigenic variation requires reversible silencing of a
repository of telomere-adjacent variant surface
glycoprotein (VSG) genes. We have investigated
the role of the telomere adjacent to a repressed
VSG. In cells lacking telomerase, the rate of
telomere-repeat loss appeared to be inversely
proportional to telomere length. We therefore con-
structed strains in which a single telomere could be
immediately removed by conditional I-SceI mega-
nuclease cleavage. Following telomere deletion,
cells maintain and segregate the damaged chromo-
some without repairing it. These cells continue to
proliferate at the normal rate but progressively lose
terminal DNA at the broken end. Although sirtuin-
dependent repression is lost along with the telo-
mere, VSG-silencing is preserved. The results
provide direct evidence for telomere-dependent
repression but suggest a telomere-independent
mode of VSG-silencing. They also indicate the
absence of a telomere-loss checkpoint in T. brucei.
INTRODUCTION
Telomeres are nucleoprotein complexes that form protec-
tive caps at the natural DNA double strand breaks
(DSBs) found at chromosome ends (1). Telomere loss or
DSBs elsewhere in the genome are potent DNA damage
response (DDR) stimuli (2). In proliferating cells, even a
single DSB triggers a DDR (3). The classical DDR
involves cell-cycle arrest and repair and ensures the
maintenance of genome integrity. G2/M arrest can last
for the length of several cell cycles (4) and, if damage is
extensive and/or not repaired, can be followed by
senescence or apoptosis. Consequently, if DDR pathways
are defective, DSBs can have profound consequences
including chromosome rearrangement and oncogenesis.
Telomeres also inﬂuence sister chromosome separation (5)
and recruit a histone deacetylase, sirtuin complex
that represses the expression of adjacent genes (6).
Thus, telomeres protect chromosome ends, inﬂuence
chromosome dynamics, repress local gene expression
and mask the DNA end from damage surveillance (7).
In the mammalian host bloodstream, Trypanosoma
brucei, the African trypanosome, escapes the immune
response through mono-telomeric expression and rever-
sible silencing of variant surface glycoprotein (VSG)
genes. Antigenic variation can occur via rare epigenetic
switching to alternative telomeric expression sites (ESs)
(8). Unusually, RNA polymerase I, a polymerase gen-
erally conﬁned to ribosomal RNA genes in eukarya,
transcribes the active VSG towards a telomere. A typical
ES is polycistronic with the promoter  50kbp from the
telomere-adjacent VSG which produces approximately
10% of total cellular protein. Trypanosoma brucei
telomeres repress RNA polymerase I transcription
within a few thousand base pairs of the telomere in a
sirtuin-dependent manner but ES silencing is sirtuin-
independent (9,10).
In total, there are probably more than 200 telomeres
in T. brucei; the majority cap the minichromosomes (11).
The specialized reverse-transcriptase known as telomerase
extends T. brucei telomeres by adding T2AG3 repeats
(10,11). Human chromosome ends are protected by a six
subunit complex known as shelterin (12) and an apparent
homologue of one of the subunits, TRF2, has been
characterized in T. brucei (13). t-loops are another feature
shared by human and T. brucei telomeres (14). Unlike the
situation in many organisms however, there is no rigorous
telomere length monitoring in T. brucei. Telomerase-
dependent extension is minimally 6bp/population dou-
bling (PD) but is increased by transcription at the
chromosome end (10,15,16), a feature that may only
aﬀect the single active ES telomere in bloodstream form
cells. Growth and occasional deletions are responsible for
highly variable telomere lengths ranging from less than
one to more than 15kbp in each cell (11).
Telomeres play key roles in regulating virulence gene
expression and recombination in a range of pathogens
and are thought to play important roles in T. brucei (17).
We established tetracycline-inducible I-SceI expression
and used this system to delete a speciﬁc T. brucei telomere.
The resulting cells allowed us to explore the role of the
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chromosome end from nucleolytic degradation and
the DDR. We show that telomeric DNA represses the
expression of adjacent genes and protects terminal DNA
from degradation. Telomeres do not appear to be required
for VSG silencing however and, remarkably, T. brucei
telomere deletion does not trigger a DDR.
MATERIALS AND METHODS
Trypanosoma brucei growth andmanipulation
All bloodstream form cells were derived from Lister 427
MITat1.2 (clone 221a) and grown in HMI-11. Cells were
transformed with linear DNA constructs as previously
described (18). Drug selection was applied as described
(19) and cell density was determined using a haemo-
cytometer. Tetracycline (Tet) was from Sigma and was
removed from the medium by washing the cells twice in
HMI-11. To estimate VSG221 reactivation frequency,
VSGX-expressing cells were pre-grown in Tet (1 mg/ml)
for 24h and then 1.5 10
6 cells were distributed into each
well of a 24-well plate in medium containing Tet and
puromycin (5mg/ml). Wells were inspected for growth
after 6 days and positive cultures were examined for
VSG221 expression.
Plasmid constructs
pHD1313 (20) was used to introduce the tetracycline-
repressor (TetR:BLE) into T. brucei. pESP
iPAC and
pESP
iRFP:PAC were used to introduce a Tet operator
(TetO) followed by a PAC gene or an RFP:PAC fusion
downstream of the VSG221 ES promoter respectively.
The upstream and downstream targeting fragments in
these two constructs were ampliﬁed by PCR from
pRK8(þ) (21) using the VTet5U (GATCGAGCTCGCA
TTTACAACTGATGCTATA), VTOp3U (GATCGGAT
CCACTCTATCATTGATAGGGTGaGTCTGATATC
CTAGATTTC) primer pair and from BAC TBH25N7
(22, Acc:AL671259) using the VTet5D (GATCGGGC
CCGGTGTGGCGGACGTCTCG), VTet3D (GATCGG
TACCGGCTGGATCAATTCCTGCAG) primer pair,
respectively. The VTOp3U primer encodes the TetO
sequence (underlined) and the ‘a’ represents the transcrip-
tion start site (21). Relevant restriction sites encoded by
the primers are in italics. The fragments were cloned either
side of a PAC gene ﬂanked by T. brucei mRNA processing
signals. The RFP:PAC fusion was assembled by ligating
RFP and PAC genes PCR ampliﬁed using the RFP5Fu
(GATCAAGCTTatgGTGCGCTCCTCCAAG), RFP3Fu
(GATCGCGGCCGCACAGGAACAGGTGGTGGCG)
primer pair with pDsRed1-C1 (Clontech) and the
PAC5Fu (GATCGCGGCCGCACCGAGTACAAGCCC
ACG), TUBIR3Fu (GATCGGGCCCCCCCTCGACT)
primer pair respectively. The RFP start codon is
indicated in lower-case. BLA and HYG constructs
were used to disrupt the telomerase gene (GeneDB
ID: Tb11.01.1950) generating homozygous tel-
omerase
i222-954 null strains (see 10). The I-SceI cleavage
site was added to the telomere-mediated fragmentation
construct, pTMF (16), by annealing the SceF
(GGCCTAGGGATAACAGGGTAAT) and SceR (GGCC
ATTACCCTGTTATCCCTA) primers and ligating
the product to NotI-digested pTMF. The I-SceI
ORF was ampliﬁed by PCR from pSCM525 using
the SceNLS (GATCAAGCTTatgCCAAAGAAGAAGC
GAAAGGTA – I-SceI codons 2–9) and Sce3
(GATCGGATCCtta - I-SceI codons 231–237) primers
such that an SV40 nuclear localization signal
(PKKKRKV, codons underlined) was encoded at the
N-terminus. Start and stop codons are indicated in lower-
case. The recombinant I-SceI gene was ligated to a
construct for Tet-on inducible expression from a RRNA
promoter. This vector is used to integrate the expression
cassette at T. brucei RRNA loci in cells expressing TetR
(19). BLA and HYG constructs were used to disrupt
the SIR2rp1 gene (GeneDB ID: Tb927.7.1690) generating
homozygous sir2rp1
i1-285 null strains (9).
DNA and RNA analysis
Southern and northern analyses were carried out accord-
ing to standard protocols. Telomere healing locations
were mapped using genomic DNA from T. brucei clones
that survived PAC selection (0.2mg/ml puromycin) after I-
SceI induction; PAC at a repressed ES was suﬃcient to
confer resistance to this concentration of puromycin.
Brieﬂy, the 221B (GGCGTTACCAAGCTTGTTGA) and
Tel2 (ACCCTA)5 primers were used to amplify the healed
end by PCR and the 221Uxho primer (N10TTTCCCC
CCTCAAATTTCCCC) was used for sequencing.
Proteinanalysis
Western blotting and ﬂuorescence microscopy were
carried out using standard protocols as previously
described (9). Brieﬂy, extracts of total cell protein were
separated on SDS-polyacrylamide gels and stained with
coomassie blue (Sigma) or subjected to western blotting
using rabbit-VSG221 and an ECL kit (Amersham). For
immunoﬂuorescence analysis, cells were labelled using
rabbit NPT-II (Europa Bioproducts) primary antibody
and ﬂuorescein-conjugated goat-rabbit secondary anti-
body (Pierce). Cells were mounted in Vectashield (Vector
Laboratories) containing 4,6-diamidino-2-phenylindole
(DAPI) and images were captured using an Eclipse E600
microscope with digital camera (Nikon) and Metamorph
software.
RESULTS
Derivation of isogenic strains with activeand repressed
VSG expression sites
Approximately twenty telomeric loci are occupied
by similar polycistronic VSG expression sites (ESs) in
T. brucei. In bloodstream form cells, all but one are
reversibly repressed and the frequency of switching is very
low, typically510
 6/PD (1 PD  7.5h). For most studies,
we use cells expressing VSG221, a single copy VSG gene
on chromosome VIa (23). To facilitate studies on this well
characterized ES in its repressed state, we expressed
the tetracycline repressor (TetR) and, in the presence of
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VSG221 ES promoter (Figure 1A). TetR-binding in
this position is expected to interfere with ES transcription.
The resulting cells continued to express VSG221 in the
presence of Tet but only cells that switched to an
alternative VSG expression site survived when Tet was
removed from the growth medium (see Figure 1B). This is
explained by the blockage of VSG221 ES transcription
that occurs when TetR binds TetO and because VSG
expression is essential for viability (25). VSG221 was
reversibly repressed in the switched clones and, under
permissive conditions (þTet), yielded ﬁve puromycin
resistant clones from 3.6 10
7 cells (equivalent to
52 10
 7/PD). All four puromycin resistant clones
tested had also reactivated VSG221 and one of these
clones is shown in Figure 1B. Thus, the approach allowed
the generation of isogenic strains with active and repressed
VSG221 ESs with unique markers at each end, PAC
adjacent to the promoter and VSG221 adjacent to the
telomere (Figure 1A). In the experiments described below,
the VSG221-associated telomere was manipulated in ‘221-
repressed’ strains while ‘221-active’ strains served as
controls when assessing loss of repression.
Shorttelomeres shrink atadiminished rate in telomerase
null mutants
To explore the role of telomeric repeats at a repressed ES
we began by engineering a short telomere in telomerase
null mutants, where terminal DNA is lost at a rate of
 4bp/PD (10,11). To establish these short and shrinking
telomeres we disrupted one allele of telomerase, used a
telomere-mediated fragmentation (pTMF) construct to
seed a telomere with 33 T2AG3 repeats at the repressed
VSG221 locus (Figure 2A) and then disrupted the second
allele of telomerase. The TMF construct also integrates
an NPT reporter adjacent to the telomere (Figure 2).
The reporter is subject to position eﬀect repression
but generates suﬃcient antibiotic resistance to allow
recombinant clone selection. Clones 1 and 2, generated
by this approach, initially had VSG221-associated T2AG3-
repeat tracts of  800bp and  1.2kbp respectively
(Figure 2B). If the rate of DNA loss remained constant
at  4bp/PD, we calculated that clone 1 repeats would
be completely lost following 200 PDs ( 60 days).
We monitored telomere length using a Southern blot
assay over a 40-day period (Figure 2B). Repeat loss in
clone 2 was only marginally lower than expected but clone
1 lost only  300bp, consistent with an average rate of
52.5bp/PD. The results suggest that the rate of DNA
loss may be inversely proportional to telomere-length.
This rate of DNA loss is too slow to be explained by
the inability of the conventional DNA replication
machinery to fully replicate chromosome termini and
indicates a telomerase-independent, possibly replication-
slippage mechanism for telomeric DNA replication. These
ﬁndings are entirely consistent with a recent report of
Figure 2. Telomerase is not required for VSG-associated repression.
(A) A telomere-mediated fragmentation construct, pTMF was used to
insert a reporter gene (NPT, neomycin phosphotransferase) driven by a
RRNA promoter (PRRNA) 5kbp from a de novo telomere at a repressed
ES in telomerase heterozygotes. Transformation using this vector
results in deletion of the native telomere and formation of a new
telomere by elongation of a (T2AG3)33 ‘seed’. (B) Following disruption
of the second allele of telomerase, Southern blotting indicates the rate
of telomere-repeat loss in the telomerase null strains. DNA extracted
at ten-day intervals was digested with HpaI, an enzyme that cleaves
immediately upstream of NPT and 5.1kbp from the telomere,
non-telomere junction (asterisk). The arrowheads indicate the expected
size if DNA were lost at 4bp/PD. (C) Immunoﬂuorescence analysis
indicates that the NPT reporter remains repressed when adjacent to a
short, shrinking telomere. NPT signals are green; blue, DAPI-stained
DNA. Scale bar, 5mm.
Figure 1. Inactivating the VSG221 ES. (A) The VSG221 ES was
rendered tetracycline (Tet)-dependent by expressing the Tet-repressor
and inserting a Tet-operator immediately downstream of the ES
promoter. PAC, puromycin N-acetylase. (B) VSG analysis. western
blotting indicates that the modiﬁed VSG221 ES is active in the presence
of Tet (1mg/ml, on). Following Tet removal, cloned survivors were
found to have switched to an alternative VSG(X) ES (oﬀ). VSG221
could be reactivated (on
2) in the presence of Tet and puromycin
(see Materials and Methods) indicating that repression is reversible.
Arrowheads indicate bands representing the abundant VSGs in the
coomassie-stained gel.
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telomeres (15). Telomere-proximal NPT reporter repres-
sion was maintained in these telomerase null cells with
short and shrinking telomeres (Figure 2C).
Telomere cleavage withI-SceI
Our attempts at complete telomere removal using
telomerase disruption were complicated by the diminished
rate of DNA loss at a short telomere. We therefore
decided to use a diﬀerent approach involving complete
and immediate in vivo telomere removal. I-SceI is a site
speciﬁc double strand homing endonuclease encoded by a
mitochondrial group I intron of Saccharomyces cerevisiae
(26). The sequence recognized and cleaved by the enzyme
is 18bp in length and is expected to appear only once in
every 6.87 10
10bp. This exceeds the size of the T. brucei
genome by 42000-fold. We introduced an I-SceI
cleavage site at the telomere – non-telomere junction
in the pTMF construct (see asterisk in Figure 2A). Speciﬁc
I-SceI cleavage of this construct was veriﬁed in vitro
(data not shown) using recombinant I-SceI (New England
BioLabs) and the DNA was targeted to the repressed
VSG221 telomere. The I-SceI ORF was then fused
to an SV40 nuclear localization signal and cloned in
a Tet-on inducible expression construct (see Materials
and Methods). This construct was targeted to a tran-
scriptionally silent locus in cells with the engineered
I-SceI site.
To determine whether I-SceI would cleave the repressed
VSG221-associated telomere, genomic DNA samples were
prepared at a number of time points up to 72h following
induced I-SceI expression. The samples were digested with
HpaI, which generates a terminal fragment encompassing
the NPT gene. Southern blotting using an NPT
probe revealed the expected terminal fragment at  7kbp
which was diminished in intensity over the time-course of
the experiment concomitant with the appearance of the
expected 5.1kbp cleavage product (Figure 3). Signiﬁcant
I-SceI cleavage had occurred only 3h after induction.
Importantly, phosphorimager analysis indicated almost
complete (495%) cleavage 24h after induction (Figures 3
and 4B) showing that I-SceI expression was tightly
regulated. Thus, I-SceI accesses and speciﬁcally cleaves
in vivo chromatin templates in T. brucei. Using inducible I-
SceI, endonuclease activity can be rapidly delivered to the
entire population of cells in a synchronous manner.
A DNA double-strand break (DSB) triggers cell cycle
arrest and DNA repair in other cell-types (reviewed in 3).
Despite DSBs in495% of cells, we detected no signiﬁcant
impact on cell growth during the time-course of this
experiment which spanned  10 PD or41000-fold increase
in cell number (Figure 3). Indeed, we saw no evidence for
cell cycle arrest or delay following telomere deletion in
several independent strains (data not shown).
A minorityof cells healthebroken chromosome following
telomere deletion
Chromosome healing at a cleaved telomere is very
eﬃcient in mammalian cells (27) and terminal G-rich or
T2AG3-repeat-like sequences can serve as substrates for
de novo telomere seeding in T. brucei (16). In addition,
telomere-repeat-like sequences adjacent to DSBs act as
‘anti-checkpoints’ in S. cerevisiae by seeding de novo
telomeres in the absence of a conventional DNA damage
response (28).
To determine the fate of terminal sequences following
telomere deletion, we carried out further Southern
analysis with the same samples used in Figure 3,
but now using a restriction enzyme that generates discrete
NPT and VSG221 fragments (indicated in Figure 4A).
More than 95% of the NPT signal and  90% of the
VSG221 signal is lost after 48h under inducing conditions
(Figure 4A and B). Almost complete loss of the NPT
signal and persistence of a residual and undiminished
VSG221 signal between 48 and 72h (Figure 4B) suggests
signiﬁcant healing between the NPT and VSG221 genes.
The only T2AG3-like tract in the VSG221 ES, that might
be expected to serve as a substrate for de novo telomere
seeding (16), lies between the NPT and VSG221 genes
Figure 3. Induction of I-SceI expression results in speciﬁc telomere
cleavage. Strains with a Tet-inducible copy of I-SceI and a unique
I-SceI cleavage site adjacent to the VSG221 telomere were grown in
Tet (1mg/ml) for three days. DNA samples extracted at various
intervals were digested with HpaI (top panel; EtBr, ethidium bromide
stain) and analysed by Southern blotting. The map to the left indicates
the expected 7kbp terminal fragment and the 5.1kbp, I-SceI cleaved
product. The phosphorimager scans to the right (0, 6 and 48h) further
illustrate the presence of the expected fragments. Blots hybridized
with a control (GeneDB ID: Tb927.7.1690) probe indicate speciﬁc
cleavage at the I-SceI site. The growth curve below the blots indicates
no signiﬁcant impact on cell growth during the time-course of the
experiment. Error bars: one standard deviation. n¼2.
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nt 211–322; 46bp of T1-2AG1-6 followed by 10.5 degen-
erate repeats; T2AG G/A G/A/C, 106bp in total). Several
independent healing events were mapped (data not shown,
see Materials and Methods) and were all found to occur
within this tract indicating that the T2AG3-like sequence
serves as a substrate for de novo telomere seeding in  10%
of cells. VSG221 remained reversibly repressed in these
‘healed’ clones as demonstrated by the emergence of
puromycin-resistant cells that also reactivated VSG221
(Figure 4B inset). Consistent with loss of the terminal
DNA segment, the NPT band is not detected in these
reactivated, ‘on
2’ cells.
Progressive loss ofsub-telomeric sequences following
telomere deletion
The results described above indicate that only approxi-
mately 10% of cells heal the chromosome end between
the NPT and VSG221 sequences. Thus, telomere deletion
leads to the loss of NPT and VSG221 DNA in the
majority of cells. From the data shown in Figure 3,
we noted that the 5.1kbp terminal fragment from which
the telomere had been cleaved became relatively less
intense by 12h and also the presence of a ‘smear’ of
smaller NPT fragments. This suggested that, rather than
being repaired, the DNA may be degraded from the
cleaved end by native exonuclease(s). The data shown in
Figure 4A and B indicates that telomere deletion is indeed
followed by diminishing NPT signal which is then
followed by diminishing VSG221 signal. Twelve hours
after I-SceI induction, for example,  90% of the cells
have a cleaved telomere,  50% of cells have lost the NPT
gene and  20% have lost the VSG221 gene (Figure 4B).
The relative rates of loss of the NPT and VSG221 signals
indicate that DNA is progressively degraded from the
DSB. The interval between approximately 50% telomere
Figure 4. A damaged chromosome is maintained but loses terminal DNA. Cells with Tet-inducible I-SceI and a unique I-SceI cleavage site adjacent
to the VSG221 telomere were grown in Tet (1mg/ml) for up to one week. DNA samples extracted at various intervals were digested with PstI( A and
C)o rHpaI (top panel in C) and analysed by Southern blotting. Data for the plots shown in B and D were derived by phosphorimager analysis of the
blots in Figures 3 and 4A, and 4C respectively. The maps to the left indicate the location of relevant probes and the I-SceI site. (A) Location of a
T2AG3-repeat-like tract is indicated by an open box. (B) Inset, VSG analysis in switched cells. Labels and clone derivation as in Figure 1B. Coo,
coomassie-stained gel. Arrow, NPT band, not seen in ‘oﬀ’ or ‘on
2’ cells. (C) Arrowhead indicates 5.1kbp cleavage-product. The chromosome II
(GeneDB ID: Tb927.2.2190) and chromosome VI control probes (GeneDB ID: Tb927.6.910) were sequentially hybridized. (D) Error bars: one
standard deviation. n ¼ 2.
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diminished signals for the NPT gene located at 4kbp from
the cleavage site is  5h (Figure 4B). Although variable
within the population, this roughly translates to a rate of
DNA loss at a broken end of 100bp every 7.5min or
6kbp/PD.
Polycistronic VSG ESs extend  50kbp from the
promoter to the telomere (see 29) and we predict a
length of  65kbp for the VSG221 expression site
following addition of the NPT and PAC cassettes
(see Figure 2A). To facilitate expression monitoring at
both ends of the VSG221 ES (see below), we replaced the
promoter-adjacent PAC gene (see Figure 1A) with a red
ﬂuorescent protein (RFP:)PAC fusion gene. Using two
independent clones with reversibly repressed RFP:PAC
and VSG221 genes, we asked whether progressive DNA
loss continues through the ES towards the core of the
chromosome following telomere deletion. Both clones
were monitored for one week after I-SceI induction,
equivalent to420PD or410
6-fold increase in cell number.
Southern blots showed speciﬁc and inducible telomere
cleavage (Figure 4C, top panel). The VSG221 ES is on
chromosome VIa (23) and signals for genes within the core
of chromosomes VI and II were stable during the course
of this analysis (Figure 4C). VSG221 and RFP:PAC
analysis indicated loss of the VSG221 signal prior to the
RFP:PAC signal (Figure 4C and D) and DNA loss
consistent with a rate of  6kbp/PD (see above). The
analysis conﬁrms that terminally deleted T. brucei
chromosomes are replicated and segregated without
being repaired.
Telomeredeletionleadstolossofsirtuin-dependentrepression
without ESde-repression
In bloodstream-form T. brucei, ectopic promoters
adjacent to telomeres are subject to sirtuin-dependent
repression while a sirtuin-independent mechanism main-
tains VSG ES silencing (9). The NPT signal in the sir2rp1
null strain (Figure 5C) conﬁrmed sirtuin-dependent
repression of the current NPT reporter but phosphorima-
ger analysis revealed only 5% NPT mRNA in SIR2rp1-
null mutants relative to the active ES reﬂecting the
quantitatively more signiﬁcant, sirtuin-independent mode
of VSG ES silencing.
Replication and segregation of a chromosome lacking a
telomere provided an opportunity to directly test the
impact of the telomere (and potentially other associated
factors) on local gene expression. We estimated the mean
DNA loss over time following I-SceI induction and this is
illustrated in Figure 5A. Then, using individual cell,
(immuno)ﬂuorescence analysis, we looked for de-repression
over a three-day time-course. This analysis revealed
transient and non-synchronous de-repression of NPT at
6 and 9h but no de-repression of VSG221 and no
de-repression of RFP (Figure 5B, the ﬁelds shown are
representative of the population and the results
were conﬁrmed with an independent clone). Transient
de-repression of NPT is consistent with the fact that it is
adjacent to a ‘broken’ end for only a short time before
being lost itself (see Figure 5A). These results suggest
that the sirtuin eﬀect spreads from within telomeric
repeats and that telomere deletion leads to loss of
sirtuin-dependent repression. Since transcription from
the ES promoter remains repressed following telomere
Figure 5. The eﬀect of telomere deletion on local gene expression.
(A) The schematic map of the VSG221 ES illustrates the reporter genes
and the mean extent of DNA loss at diﬀerent time points following
I-SceI induction (based on DNA loss at 6kbp/PD). Reporter
expression was assessed following I-SceI induced (þTet) telomere
deletion. The VSG221 ES is permissive for activation under these
conditions (see Figure 1). (B) Immunoﬂuorescence (NPT, VSG221) and
ﬂuorescence (RFP) analysis reveals transient, non-synchronous loss of
telomeric silencing (NPT) but otherwise maintained ES repression
(VSG221, RFP). Numbers indicate hours following I-SceI induction.
NPT and VSG signals are green; RFP signals are red; blue, DAPI-
stained DNA. Scale bar, 5mm. (C) Northern (left-hand side) and
western (right-hand side) blot analysis. Numbers indicate hours
following I-SceI induction. mRNA expression was also analysed in
sir2rp1 null mutants and in cells with an active VSG221 ES (on).
For northern analysis, tubulin (TUB) is used as a loading control and
for western analysis, an equivalent coomassie (Coo) stained gel is
shown as a loading control.
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additional repressive eﬀect spreading from the telomere.
In fact, despite the longer time frame between telomere
deletion and RFP loss (Figure 5A), RFP de-repression is
not seen at any point during progressive loss of ES
sequences. This suggests that the VSG and associated
sequences are also not required for maintained ES
silencing.
Maintained silencing of RFP and VSG221 was con-
ﬁrmed by northern blotting with RNA extracted at
a number of time points following I-SceI induction
(Figure 5C). Although the low-abundance NPT mRNA
is not detected by northern blot following I-SceI induc-
tion, we were able to conﬁrm NPT de-repression by
western blot (Figure 5C). The results are consistent
with sirtuin-dependent telomeric gene silencing but
suggest that ES silencing is sirtuin and telomere-
independent.
DISCUSSION
We removed a T. brucei telomere in vivo to explore its role
in gene repression and in protecting the chromosome end
from endonucleolytic degradation and the DDR. Initially,
we demonstrated terminal DNA loss at 52.5bp/PD in
telomerase null strains, consistent with a recent report
showing that short T. brucei telomeres are stabilized in a
telomerase-independent manner (15). Telomere removal
was then achieved using meganuclease cleavage, and
subsequent experiments using unique sub-terminal repor-
ters indicated telomere-dependent gene-repression and
telomere-dependent protection of adjacent DNA from
rapid degradation. Telomere deletion has little impact on
VSG ES silencing however and, surprisingly, does not
trigger a DDR in T. brucei.
Telomeres provide substrates for telomerase and
are essential for maintaining chromosome stability (1).
Whereas T. brucei telomerase null strains lose telomeric
DNA at a rate of  4bp/PD or less, a broken chromosome
end progressively loses terminal DNA at a rate averaging
6000bp/PD. This41000-fold higher rate of DNA-loss at
an uncapped chromosome end illustrates the protective
eﬀect of T2AG3 repeats, even in the absence of telomerase.
The data reveal nucleolytic activity that is normally
excluded from the chromosome end, likely due to the
formation of t-loops (14) stabilized by telomere-associated
factors (13). Loss of these structures exposes substrates for
nucleolytic degradation.
The two major pathways of DNA repair are non-
homologous end-joining (NHEJ) and homologous recom-
bination (HR). Single-celled organisms rely more heavily
on HR (30) and, in haploid yeast, sub-telomeric DSB-
repair more commonly involves HR while NHEJ
eﬃciency correlates with distance from the chromosome
end (31). Trypanosomatid genome sequence analysis
revealed components of most repair pathways and also a
number of NHEJ components although H2AX is notably
absent (32). Many DNA repair factors are associated with
telomeres (2) and this also appears to be the case in
T. brucei where the Ku70/80 heterodimer (33,34) and a
sirtuin (9) have been shown to inﬂuence telomere
extension and silencing respectively. Trypanosoma brucei
cells lacking RAD51 (35,36), Mre11 (37,38) or the sirtuin
(9) do not display delay in progression through the cell
cycle but they are all more sensitive to DNA damage
induced by ionizing radiation or radiomimetic drugs.
In striking contrast to the situation in most other
eukaryotes, a terminally truncated and un-repaired
T. brucei chromosome is maintained and segregated with
no signiﬁcant impact on growth. In other proliferating
cells, DSBs induce a DDR (39). In S. cerevisiae,
for example, chromosome ends with either few or no
telomeric repeats (1), and even a DSB in a dispensable
plasmid, trigger cell-cycle arrest and DNA repair (40).
Some cells do recover but go on to lose the aﬀected
chromosome (1). Similarly, only fused or repaired
chromosomes are recovered when a DSB is introduced
near a telomere in mammalian cells (41). The absence of
a conventional telomere checkpoint and consequent fail-
ure to repair a truncated chromosome may eventually lead
to chromosome loss and cell death. Although a large body
of evidence suggests that telomere loss elicits the same
response as a DSB elsewhere in the genome (2), it has been
proposed that the telomere checkpoint is distinct from the
DNA damage checkpoint in S. cerevisiae (42). In addition,
terminally truncated telomeres can be protected in a
sequence-independent manner in Drosophila (43). Thus, I-
SceI-cleaved T. brucei telomeres may recruit or retain
factors that protect the terminus from the DDR. It will be
important to introduce DSBs elsewhere in the T. brucei
genome to assess how the DDR machinery responds to
damage elsewhere.
Our data show that, before being lost, a reporter 5kbp
from the deleted telomere is de-repressed and this provides
direct evidence for telomere-dependent gene repression in
T. brucei. We show that this same reporter is subject to
sirtuin-dependent silencing. In S. cerevisiae, telomeric
silencing is dependent upon recruitment of a histone
deacetylase, sirtuin-complex (6) and we speculate that it is
the sirtuin eﬀect that is lost along with the telomere in
T. brucei. Our results suggest however that VSG ES
silencing, which relies upon transcription attenuation (44),
is not only sirtuin-independent (9) but is also telomere-
independent. Thus, telomeric repression and ES silencing
appear to be mechanistically distinct.
Although telomeres are not required to maintain ES
silencing, they do repress genes in the vicinity of the VSG
so that they may act in a cooperative manner to fully
silence the large VSG repertoire. This includes the
monocistronic, ‘metacyclic’ VSG ESs that are transcribed
from promoters in close proximity to the telomere during
the ﬁrst week of a mammalian infection (8). In addition,
we cannot rule out a role for the telomere in establishment
of ES silencing since telomere deletion may not reverse
telomere-mediated DNA or chromatin modiﬁcation,
for example. The telomere may also play a role in active
ES transcription and/or recombination.
Trypanosoma brucei telomeres protect chromosome
ends from degradation and repress local gene expression
but appear to have little impact on ES silencing or
chromosome segregation and fail to trigger a DDR when
878 Nucleic Acids Research, 2007, Vol. 35, No. 3deleted. Using meganuclease manipulation, it should
now be possible to examine the consequences that
follow active ES deletion and the introduction of DSBs
at non-telomeric loci.
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